Bilateral transfemoral lower extremity transplantation: Result at 1 year

American Journal of Transplantation

Volumn 13, Issue 5, 2013, Pages 1343-1349

  Cavadas, P C ^a   Thione, A ^a   Carballeira, A ^a   Blanes, M ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bilateral AK amputee; composite tissue allotransplantation; transfemoral transplantation

Indexed keywords

ALEMTUZUMAB; AZTREONAM; CLOPIDOGREL; GANCICLOVIR; GEMFIBROZIL; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DEBRIDEMENT; DIARRHEA; DONOR; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; EXERCISE; FOLLOW UP; FRACTURE HEALING; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; JOINT CHARACTERISTICS AND FUNCTIONS; LEG REVASCULARIZATION; LEUKOCYTE COUNT; LOWER EXTREMITY TRANSPLANTATION; MALE; NEUTROPENIA; PLANTAR FLEXION; PRIORITY JOURNAL; RANGE OF MOTION; REHABILITATION; SURGICAL APPROACH; SURGICAL INFECTION; TRANSPLANTATION; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS REPLICATION; WALKING;

ADULT; AMPUTATION, TRAUMATIC; AMPUTEES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEG; MALE; ORGAN TRANSPLANTATION; TIME FACTORS; TISSUE DONORS; YOUNG ADULT;

EID: 84876947954     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12178     Document Type: Article

References (20)

1. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue. Transplantation 2010; 90: 1590-1594.
2. Wu S, Xu H, Ravindra K, Ildstad ST,. Composite tissue allotransplantation: Past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. Transplant Proc 2009; 41: 463-465.
3. Hollenbeck ST, Erdmann D, Levin LS,. Current indications for hand and face allotransplantation. Transplant Proc 2009; 41: 495-498.
4. Cavadas PC, Ibáñez J, Thione A, Alfaro L,. Bilateral trans-humeral arm transplantation: Result at 2 years. Am J Transplant 2011; 11: 1085-1090.
5. Bondurant FJ, Cotler HB, Buckle R, Miller-Crotchett P, Browner BD,. The medical and economic impact of severely injured lower extremities. J Trauma 1988; 28: 1270-1273.
6. Hierner R, Berger AK, Frederix PR,. Lower leg replantation-Decision- making, treatment, and long-term results. Microsurgery 2007; 27: 398-410.
7. Cavadas PC, Landín L, Ibáñez J, Roger I, Nthumba P,. Infrapopliteal lower extremity replantation. Plast Reconstr Surg 2009; 124: 532-539.
8. Kidney Disease Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 (Suppl): S46-S48.
9. Kumar D, Chernenko S, Moussa G, et al. Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant 2009; 9: 1214-1222.
10. Crouse SF, Lessard CS, Rhodes J, Lowe RC,. Oxygen consumption and cardiac response of short-leg and long-leg prosthetic ambulation in a patient with bilateral above-knee amputation: Comparisons with able-bodied men. Arch Phys Med Rehabil 1990; 71: 313-317.
11. Hagberg K, Brånemark R,. One hundred patients treated with osseointegrated transfemoral amputation prostheses-Rehabilitation perspective. J Rehabil Res Dev 2009; 46: 331-344.
12. Battiston B, Tos P, Pontini I, Ferrero S,. Lower limb replantations: Indications and a new scoring system. Microsurgery 2002; 22: 187-192.
13. Kutz JE, Jupiter JB, Tsai TM,. Lower limb replantation a report of nine cases. Foot Ankle 1983; 3: 197-202.
14. Schneeberger S, Lucchina S, Lanzetta M, et al. Cytomegalovirus-related complications in human hand transplantation. Transplantation 2005; 80: 441-447.
15. Zhang LF, Wang YT, Tian JH, Yang KH, Wang JQ,. Preemptive versus prophylactic protocol to prevent cytomegalovirus infection after renal transplantation: A meta-analysis and systematic review of randomized controlled trials. Transpl Infect Dis 2011; 13: 622-632.
16. George B, Pati N, Gilroy N, et al. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis 2010; 12: 322-329.
17. Casadei DH, del C, Rial M, Opelz G, et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001; 71: 53-58.
18. Morelon E, Kanitakis J, Petruzzo P,. Immunological issues in clinical composite tissue allotransplantation: Where do we stand today ? Transplantation 2012; 93: 855-859.
19. Glaus SW, Johnson PJ, Mackinnon SE,. Clinical strategies to enhance nerve regeneration in composite tissue allotransplantation. Hand Clin 2011; 27: 495-509.
20. Kim DH, Murovic JA, Tiel R, Kline DG,. Management and outcomes in 353 surgically treated sciatic nerve lesions. J Neurosurg 2004; 101: 8-17.